Global Naproxen Market Insights, Forecast to 2025

Description

The global Naproxen market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Naproxen market based on company, product type, end user and key regions.

This report studies the global market size of Naproxen in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Naproxen in these regions.
This research report categorizes the global Naproxen market by top players/brands, region, type and end user. This report also studies the global Naproxen market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Teva
Kirsch Pharma GmbH
Aurobindo
Divis Laboratories
Taj Pharmaceuticals Limited
Tianxin Pharmaceutical
Charioteer Pharmaceutical
Nhwa Pharmaceutical
Huazhong Pharma

Market size by Product
Tablet
Capsule
Other
Market size by End User
Rheumatoid Arthritis
Gout
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Naproxen market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Naproxen market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Naproxen companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Naproxen submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Naproxen are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Naproxen market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Study Coverage
1.1 Naproxen Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Naproxen Market Size Growth Rate by Product
1.4.2 Tablet
1.4.3 Capsule
1.4.4 Other
1.5 Market by End User
1.5.1 Global Naproxen Market Size Growth Rate by End User
1.5.2 Rheumatoid Arthritis
1.5.3 Gout
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Naproxen Market Size
2.1.1 Global Naproxen Revenue 2014-2025
2.1.2 Global Naproxen Sales 2014-2025
2.2 Naproxen Growth Rate by Regions
2.2.1 Global Naproxen Sales by Regions
2.2.2 Global Naproxen Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Naproxen Sales by Manufacturers
3.1.1 Naproxen Sales by Manufacturers
3.1.2 Naproxen Sales Market Share by Manufacturers
3.1.3 Global Naproxen Market Concentration Ratio (CR5 and HHI)
3.2 Naproxen Revenue by Manufacturers
3.2.1 Naproxen Revenue by Manufacturers (2014-2019)
3.2.2 Naproxen Revenue Share by Manufacturers (2014-2019)
3.3 Naproxen Price by Manufacturers
3.4 Naproxen Manufacturing Base Distribution, Product Types
3.4.1 Naproxen Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Naproxen Product Type
3.4.3 Date of International Manufacturers Enter into Naproxen Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Naproxen Sales by Product
4.2 Global Naproxen Revenue by Product
4.3 Naproxen Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Naproxen Breakdown Data by End User

6 North America
6.1 North America Naproxen by Countries
6.1.1 North America Naproxen Sales by Countries
6.1.2 North America Naproxen Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Naproxen by Product
6.3 North America Naproxen by End User

7 Europe
7.1 Europe Naproxen by Countries
7.1.1 Europe Naproxen Sales by Countries
7.1.2 Europe Naproxen Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Naproxen by Product
7.3 Europe Naproxen by End User

8 Asia Pacific
8.1 Asia Pacific Naproxen by Countries
8.1.1 Asia Pacific Naproxen Sales by Countries
8.1.2 Asia Pacific Naproxen Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Naproxen by Product
8.3 Asia Pacific Naproxen by End User

9 Central & South America
9.1 Central & South America Naproxen by Countries
9.1.1 Central & South America Naproxen Sales by Countries
9.1.2 Central & South America Naproxen Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Naproxen by Product
9.3 Central & South America Naproxen by End User

10 Middle East and Africa
10.1 Middle East and Africa Naproxen by Countries
10.1.1 Middle East and Africa Naproxen Sales by Countries
10.1.2 Middle East and Africa Naproxen Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Naproxen by Product
10.3 Middle East and Africa Naproxen by End User

11 Company Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Company Business Overview
11.1.3 Teva Naproxen Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Teva Naproxen Products Offered
11.1.5 Teva Recent Development
11.2 Kirsch Pharma GmbH
11.2.1 Kirsch Pharma GmbH Company Details
11.2.2 Company Business Overview
11.2.3 Kirsch Pharma GmbH Naproxen Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Kirsch Pharma GmbH Naproxen Products Offered
11.2.5 Kirsch Pharma GmbH Recent Development
11.3 Aurobindo
11.3.1 Aurobindo Company Details
11.3.2 Company Business Overview
11.3.3 Aurobindo Naproxen Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Aurobindo Naproxen Products Offered
11.3.5 Aurobindo Recent Development
11.4 Divis Laboratories
11.4.1 Divis Laboratories Company Details
11.4.2 Company Business Overview
11.4.3 Divis Laboratories Naproxen Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Divis Laboratories Naproxen Products Offered
11.4.5 Divis Laboratories Recent Development
11.5 Taj Pharmaceuticals Limited
11.5.1 Taj Pharmaceuticals Limited Company Details
11.5.2 Company Business Overview
11.5.3 Taj Pharmaceuticals Limited Naproxen Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Taj Pharmaceuticals Limited Naproxen Products Offered
11.5.5 Taj Pharmaceuticals Limited Recent Development
11.6 Tianxin Pharmaceutical
11.6.1 Tianxin Pharmaceutical Company Details
11.6.2 Company Business Overview
11.6.3 Tianxin Pharmaceutical Naproxen Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Tianxin Pharmaceutical Naproxen Products Offered
11.6.5 Tianxin Pharmaceutical Recent Development
11.7 Charioteer Pharmaceutical
11.7.1 Charioteer Pharmaceutical Company Details
11.7.2 Company Business Overview
11.7.3 Charioteer Pharmaceutical Naproxen Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Charioteer Pharmaceutical Naproxen Products Offered
11.7.5 Charioteer Pharmaceutical Recent Development
11.8 Nhwa Pharmaceutical
11.8.1 Nhwa Pharmaceutical Company Details
11.8.2 Company Business Overview
11.8.3 Nhwa Pharmaceutical Naproxen Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Nhwa Pharmaceutical Naproxen Products Offered
11.8.5 Nhwa Pharmaceutical Recent Development
11.9 Huazhong Pharma
11.9.1 Huazhong Pharma Company Details
11.9.2 Company Business Overview
11.9.3 Huazhong Pharma Naproxen Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Huazhong Pharma Naproxen Products Offered
11.9.5 Huazhong Pharma Recent Development

12 Future Forecast
12.1 Naproxen Market Forecast by Regions
12.1.1 Global Naproxen Sales Forecast by Regions 2019-2025
12.1.2 Global Naproxen Revenue Forecast by Regions 2019-2025
12.2 Naproxen Market Forecast by Product
12.2.1 Global Naproxen Sales Forecast by Product 2019-2025
12.2.2 Global Naproxen Revenue Forecast by Product 2019-2025
12.3 Naproxen Market Forecast by End User
12.4 North America Naproxen Forecast
12.5 Europe Naproxen Forecast
12.6 Asia Pacific Naproxen Forecast
12.7 Central & South America Naproxen Forecast
12.8 Middle East and Africa Naproxen Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Naproxen Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

Checkout Inquiry Sample